Literature DB >> 9085183

Pathogenic diversity of Helicobacter pylori.

F Mégraud1.   

Abstract

Helicobacter pylori has been shown to possess a very heterogeneous genoma despite its common phenotypic properties. Some characteristics relevant to pathogenesis have also been found to be heterogeneous. This is the case for adherence properties and the amount of urease produced, but it was not possible to relate these properties to disease entities. A vacuolating cytotoxin which alters epithelial cells has been found in about 60% of strains isolated from patients with ulcers versus 30% from those with gastritis only. The cagA gene can be used as a marker to detect the cag pathogenicity island. This DNA fragment seems to induce an increased inflammation in the gastric tissue via release of interleukin 8 by the epithelial cells. The association of this marker is strongly linked with ulcers compared with gastritis only (80% vs 55%, respectively). A number of other properties may be heterogeneous, but the low number of strains studied does not allow conclusions to be drawn.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9085183     DOI: 10.1007/bf02936383

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  18 in total

1.  Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology.

Authors:  J E Crabtree; J D Taylor; J I Wyatt; R V Heatley; T M Shallcross; D S Tompkins; B J Rathbone
Journal:  Lancet       Date:  1991-08-10       Impact factor: 79.321

2.  Further evidence of the toxic effect of ammonia produced by Helicobacter pylori urease on human epithelial cells.

Authors:  F Mégraud; V Neman-Simha; D Brügmann
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

3.  Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype.

Authors:  J E Crabtree; A Covacci; S M Farmery; Z Xiang; D S Tompkins; S Perry; I J Lindley; R Rappuoli
Journal:  J Clin Pathol       Date:  1995-01       Impact factor: 3.411

4.  Role of the Helicobacter pylori virulence factors vacuolating cytotoxin, CagA, and urease in a mouse model of disease.

Authors:  P Ghiara; M Marchetti; M J Blaser; M K Tummuru; T L Cover; E D Segal; L S Tompkins; R Rappuoli
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

5.  Differences in urease activity in live Helicobacter pylori cultured from patients with gastroduodenal diseases.

Authors:  S Ito; Y Kohli; T Kato; H Murakita; Y Ohotaki; M Hirai; T Azuma; M Kuriyama
Journal:  Eur J Gastroenterol Hepatol       Date:  1995-08       Impact factor: 2.566

6.  Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity.

Authors:  T L Cover; C P Dooley; M J Blaser
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

Review 7.  Toxic factors of Helicobacter pylori.

Authors:  F Mégraud
Journal:  Eur J Gastroenterol Hepatol       Date:  1994-12       Impact factor: 2.566

8.  Helicobacter pylori-associated ammonia production enhances neutrophil-dependent gastric mucosal cell injury.

Authors:  M Suzuki; S Miura; M Suematsu; D Fukumura; I Kurose; H Suzuki; A Kai; Y Kudoh; M Ohashi; M Tsuchiya
Journal:  Am J Physiol       Date:  1992-11

9.  Biochemical aspects of Helicobacter pylori colonization of the human gastric mucosa.

Authors:  T Wadström; S Hirmo; T Borén
Journal:  Aliment Pharmacol Ther       Date:  1996-04       Impact factor: 8.171

10.  Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer.

Authors:  A Covacci; S Censini; M Bugnoli; R Petracca; D Burroni; G Macchia; A Massone; E Papini; Z Xiang; N Figura
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

View more
  1 in total

1.  Phase variation in the Helicobacter pylori phospholipase A gene and its role in acid adaptation.

Authors:  T Tannaes; N Dekker; G Bukholm; J J Bijlsma; B J Appelmelk
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.